ライフサイエンスコーパス: racial

1 ) versus Asians (44.1 +/- 14.0 h), Bi-/multi-racial (48.0 +/- 16.0 h), and Whites (50.2 +/- 2.6 h).

2 porting of performance among diverse ethnic, racial, age, and sex groups for all new artificial intel

3 ases, population density, median income, and racial and age demographics.

4 y for black men in the USA, and would reduce racial and educational disparities in mortality.

5 al sciences include individuals from certain racial and ethnic backgrounds, individuals with disabili

6 wth in disparities in health outcomes across racial and ethnic categories.

7 facility differs according to the facility's racial and ethnic composition, we examined dialysis faci

8 To test if racial and ethnic differences in dialysis discontinuatio

9 Racial and ethnic differences in dialysis discontinuatio

10 More information is needed about racial and ethnic differences in outcomes from Covid-19.

11 We aimed to identify racial and ethnic differences in presentation and outcom

12 Our aim was to describe the racial and ethnic differences in presentation, baseline

13 Previous studies have demonstrated racial and ethnic differences in prevalence of abdominal

14 Data regarding racial and ethnic differences in response to S/V are lac

15 There are racial and ethnic differences in the incidence of gastri

16 In our very healthy cohort, racial and ethnic disparities in access to transplantati

17 In our very healthy cohort, racial and ethnic disparities in access to transplantati

18 In summary, racial and ethnic disparities in childhood CNS tumor sur

19 ess communities of color might contribute to racial and ethnic disparities in knowledge and behavior

20 We investigated racial and ethnic disparities in patterns of COVID-19 te

21 Racial and ethnic disparities in vaccination rates for s

22 Further investigation into causes of racial and ethnic disparities is necessary to improve ac

23 Important among these are the lack of racial and ethnic diversity in genomics studies and bior

24 is, whether a school emphasizes the value of racial and ethnic diversity, predicts better cardiometab

25 and genome-wide PRSs with CHD in three major racial and ethnic groups in the U.S.

26 d cerebrovascular risk and disparities among racial and ethnic groups in the United States, but these

27 in science, students who belong to excluded racial and ethnic groups leave science at unacceptably h

28 ults 50 years of age or older from different racial and ethnic groups of the same age, with the thinn

29 emiology and progression of IBD in different racial and ethnic groups, and the effects of race and et

30 s similar to those found among whites across racial and ethnic groups, differences in survival were m

31 nocarcinoma in specific anatomic sites among racial and ethnic groups, with significant age and sex d

32 dians and Alaska Natives compared with other racial and ethnic groups.

33 nd health care, and enhancing allyship among racial and ethnic groups.

34 shaped by differences in risk factors across racial and ethnic groups.

35 mic status and were independent of age, sex, racial and ethnic identity, and pubertal status.

36 (COVID-19) pandemic has exposed longstanding racial and ethnic inequities in health risks and outcome

37 H improves the accuracy of risk models among racial and ethnic minorities and could guide use of prev

38 of the available data on palliative care in racial and ethnic minorities and people with lower SES h

39 In the United States, racial and ethnic minorities and people with lower socio

40 nificantly higher risks of gastric cancer in racial and ethnic minorities and smokers.

41 these patients, survival differences between racial and ethnic minorities and whites were largely att

42 young adults (12 to 25 years), females, and racial and ethnic minorities at increased risk for STIs.

43 tent differences in the use of surgery among racial and ethnic minorities between the time periods 20

44 Racial and ethnic minorities on dialysis survive longer

45 tions, such as children, pregnant women, and racial and ethnic minorities.

46 ed between clinical outcomes and costs among racial and ethnic minorities.

47 SARS-CoV-2 spread need to especially target racial and ethnic minority and densely populated communi

48 There is growing concern that racial and ethnic minority communities around the world

49 to contain and prevent further outbreaks in racial and ethnic minority communities.

50 services often is substantially lower among racial and ethnic minority groups, rural residents, and

51 known, and collectively, are as important in racial and ethnic minority populations as they are in ma

52 Yet women and especially racial and ethnic minority populations remain underrepre

53 incidence of Covid-19 among underserved and racial and ethnic minority populations, the safety and e

54 ision medicine and cardiovascular disease in racial and ethnic minority populations.

55 More data regarding racial and ethnic responses to heart failure and reduced

56 ly violent Islamist revivalism and resurgent racial and ethnic supremacism.

57 ian, Hispanic, Native American, Bi- or Multi-racial and Pacific Islander.

58 Previously observed racial and sex disparities in living donor kidney transp

59 ntraindication may have inadvertently caused racial and sex disparities in metformin prescription amo

60 eGFR-based contraindication may have reduced racial and sex disparities in metformin prescription in

61 In the modern era, racial and sex disparities in mortality and postoperativ

62 Despite increasing ethnic/racial and sex diversity in U.S. medical schools and res

63 revious studies have demonstrated effects of racial and socioeconomic factors on survival of adults w

64 s higher infection rates among disadvantaged racial and socioeconomic groups(2-8) solely as the resul

65 nance of health inequities, especially along racial and socioeconomic lines.

66 The primary exposure was the racial and/or ethnic category: White or non-Hispanic ver

67 Few studies have evaluated COVID-19-related racial and/or ethnic disparities in radiology.

68 ore likely to acquire HIV due to structural, racial, and criminal justice-related factors than have W

69 ase (GBD) regions, reflective of the ethnic, racial, and gender diversity in this global epidemic.

70 resent in human subjects of different ethnic/racial backgrounds, with longer micropore lifetime in sk

71 ma susceptibility in older adults of diverse racial backgrounds.

72 Quantity of contact, implicit racial bias and negatively valenced contact showed no ef

73 and search decisions suffer from persistent racial bias and point to the value of policy interventio

74 g millions of patients, exhibits significant racial bias: At a given risk score, Black patients are c

75 ese findings suggest that acknowledging that racial biases and racial disparities in education go han

76 some measures of predictive accuracy, large racial biases arise.

77 Results showed significant racial biases, including more and quicker shooting of Bl

78 onstrates collusion between epidemiology and racial capitalism because it obscures structural influen

79 s' liability for worker health, illustrating racial capitalism operating within public health.

80 n the outbreak and review how they exemplify racial capitalism.

81 n the field of nutrition, abandon the use of racial categories to explain biologic phenomena but inst

82 care, yet providers are often unaware of the racial composition of the study populations they are bas

83 ed controlled trials (RCTs), focusing on the racial composition of their study populations.

84 1992 and 2015 suggest that newborn-physician racial concordance is associated with a significant impr

85 mens, which represent appropriate gender and racial demographics amongst HS patients.

86 The aging population and racial demographics impact projections for future eye di

87 (T), and neurodegeneration (N) for potential racial differences and (2) considers mediating effects o

88 dence of selection bias in the estimation of racial differences for these incident risk factors.

89 We designed a prospective trial to study racial differences in (1) NP levels among young adults,

90 th moderate loss to follow-up, we contrasted racial differences in 2 stroke risk factors, incident hy

91 s with acute heart failure may be related to racial differences in activity of the renin-angiotensin-

92 y area-level SES, may contribute to observed racial differences in AD.

93 development, but few studies have quantified racial differences in AKI incidence after this procedure

94 We did not observe any racial differences in expression of genes encoding for N

95 Racial differences in GBS disease rates have been previo

96 We sought to determine if the racial differences in influenza vaccination among nursin

97 Despite racial differences in mortality and attrition, we found

98 Sex and racial differences in network size, network strength, an

99 ether diuretic efficiency is associated with racial differences in risk for rehospitalization after a

100 o evaluate the risk factors that may explain racial differences in SCD risk in the general population

101 ion-based cohort, REasons for Geographic And Racial Differences in Stroke (REGARDS) (enrolled 2003-20

102 = 7,999) from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, a national

103 selected from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, a US cohor

104 >=45 years in the Reasons for Geographic and Racial Differences in Stroke study (2003-2007).

105 he REGARDS study (Reasons for Geographic and Racial Differences in Stroke) 4 decades later.

106 sing the REGARDS (Reasons for Geographic and Racial Differences in Stroke) cohort study, we studied 2

107 ded 1122 REGARDS (Reasons for Geographic and Racial Differences in Stroke) study participants with in

108 from the REGARDS (REasons for Geographic And Racial Differences in Stroke) study, weighted to the US

109 The REGARDS (REasons for Geographic and Racial Differences in Stroke) trial is a prospective coh

110 RDS cohort study (Reasons for Geographic and Racial Differences in Stroke), a national population-bas

111 he REGARDS study (Reasons for Geographic and Racial Differences in Stroke).

112 Moreover, there were significant racial differences in the demographics and anatomic char

113 We then assessed racial differences in the probability of waitlisting whi

114 Post-hoc analyses indicated that racial differences may exist in these effects.

115 [95% CI]: 2.5 [1.2-5.1]), accounted for some racial differences, and changes to Kidney Allocation Sys

116 Violent behavior, police brutality, and racial discrimination are currently at the forefront of

117 Frequency of self-reported experiences of racial discrimination in domains such as employment, hou

118 depressive symptomatology and experience of racial discrimination, and positive associations only am

119 ould include policies that address issues of racial discrimination.

120 nd media attention, but we know little about racial disparities among younger adults with CRC.

121 Racial disparities are central in the national conversat

122 We explore concordance in a setting where racial disparities are particularly severe: childbirth.

123 the post drug-eluting stent era, studies of racial disparities CABG are outdated.

124 ously lower HIV incidence overall and reduce racial disparities despite current gaps in PrEP care.

125 k for later-life complex disorders for which racial disparities exist.

126 Racial disparities have been reported in liver transplan

127 Racial disparities identified in this study warrant furt

128 Mathematics (STEM) pipeline that perpetuate racial disparities in academia.

129 and that LDN programs may mitigate existing racial disparities in access to LDKT.

130 vitamin D-PTH endocrine system contribute to racial disparities in cardiovascular health.

131 st that acknowledging that racial biases and racial disparities in education go hand-in-hand may be a

132 Studies have illuminated racial disparities in funding, likely because of implici

133 More studies are needed to characterize the racial disparities in GBS rates, and factors driving the

134 Longstanding racial disparities in heart failure (HF) outcomes exist

135 complex interplay of factors that influence racial disparities in HF incidence, prevalence, and dise

136 en traditional explanations for the observed racial disparities in HF outcomes, contemporary data sug

137 malignant LVH among blacks may contribute to racial disparities in HF risk.

138 factors are now emerging as determinants of racial disparities in OC.

139 PK transplantation is imperative to mitigate racial disparities in outcomes observed at the national

140 We assessed racial disparities in policing in the United States by c

141 There is a paucity of data examining racial disparities in those patients.

142 We examined racial disparities in young-onset CRC by comparing CRC i

143 gnosis following myocardial infarction (MI), racial disparities persist.

144 ep-related breathing and medication use, and racial disparities relate to short sleep.

145 fficers, making it difficult to test whether racial disparities vary by officer characteristics.

146 g economics, employment, community networks, racial disparities, how we treat older adults, and the p

147 t all five ASR systems exhibited substantial racial disparities, with an average word error rate (WER

148 as a strategy to lower HF risk and mitigate racial disparities.

149 s (p < 0.01) but not in AAs; (2) PHG and its racial disparity are differentiated across ages and the

150 nomena may have contributed to the growth in racial disparity in diabetes incidence.

151 d occur despite the absence of a significant racial disparity in evaluation initiation.

152 The racial disparity in incidence in this observed scenario

153 Racial disparity in kidney transplant wait-listing persi

154 Racial disparity in kidney transplant waitlisting persis

155 In this study, we examined whether the racial disparity in KT waitlisting persists after adjust

156 on hold a remarkable implication for erasing racial disparity in PCa.

157 A major racial disparity in prostate cancer (PCa) is that Africa

158 rated factors that may explain this apparent racial disparity in psoriasis treatment by comparing the

159 e need to identify novel factors that impact racial disparity in transplant wait-listing.

160 e need to identify novel factors that impact racial disparity in transplant waitlisting.

161 e landscape with a far-reaching influence on racial disparity to subtypes of breast cancer.

162 Racial disparity was observed with Hispanics, Asians and

163 ble portfolio standards, taking into account racial, ethnic, and economic inequality in air pollutant

164 ions, and deaths have emerged as a signal of racial, ethnic, and financial disparities.

165 ted States, with unacceptably high rates and racial, ethnic, and geographic disparities.

166 leation rates decreased over time across all racial, ethnic, and socioeconomic groups.

167 lts: Existing LCS guidelines do not consider racial, ethnic, socioeconomic, and sex-based differences

168 23.0), verbal-sexual (13.2%, 10.2-16.2), and racial-ethnic (11.6%, 9.2-14.0).

169 and examine interactions indicating whether racial-ethnic disparities in intake were modified by inc

170 g early childhood and adulthood approximated racial/ethnic and economic dimensions of neighborhood pr

171 Racial/ethnic and religious minority categories were bli

172 access may explain the absence of effect of racial/ethnic and socioeconomic disparities on death.

173 f prevention efforts to reduce and eliminate racial/ethnic and socioeconomic disparities.

174 versity and inclusion efforts to improve the racial/ethnic and socioeconomic representativeness of AD

175 physical activity regardless of age, income, racial/ethnic background, ability, or disability.

176 State Medicaid expansion status and racial/ethnic category.

177 Racial/ethnic characteristics (48% African American, 31%

178 Whether there are racial/ethnic difference among adults with AD and the ca

179 or each income category, indicating that the racial/ethnic differences hold even after accounting for

180 the non-Hispanic White (NHW) population, but racial/ethnic differences in age at death are not known.

181 ver, existing references fail to account for racial/ethnic differences in body composition among chil

182 Racial/ethnic differences in HIV care persist in specifi

183 Although previous studies have explored racial/ethnic differences in incident atopic dermatitis

184 The impact of racial/ethnic differences in mutational load on placenta

185 Racial/ethnic differences in pathogenic variants include

186 tionale: Limited information is available on racial/ethnic differences in pulmonary arterial hyperten

187 There were also large racial/ethnic differences in the types of SSBs consumed.

188 Racial/ethnic differences were examined by cross-product

189 f surgeons of color witnessed or experienced racial/ethnic discrimination.

190 However, whether racial/ethnic disparities exist in access to SLKT and po

191 We found no racial/ethnic disparities in all-cause mortality or use

192 Racial/ethnic disparities in all-cause stroke among hemo

193 to reflect, perpetuate, and even exacerbate racial/ethnic disparities in health and health care.

194 We also found evidence of racial/ethnic disparities in PBDE exposures (Non-Hispani

195 medical eligibility do not appear to explain racial/ethnic disparities in receipt of kidney transplan

196 we 1) summarize current evidence related to racial/ethnic disparities in sleep health and within-gro

197 ents with atrial fibrillation, investigating racial/ethnic disparities in stroke among such patients

198 sex contact) on the magnitude of HIV-related racial/ethnic disparities is not well understood.

199 associated with preterm delivery and related racial/ethnic disparities using intergenerationally link

200 efforts are also needed to reduce persistent racial/ethnic disparities, particularly to improve treat

201 Racial/ethnic disparity in outcome persists despite a st

202 ous psychological distress (SPD) have lacked racial/ethnic diversity and generalizability.

203 oncology patients based on socioeconomic and racial/ethnic factors.

204 e release of national COVID-19 death data by racial/ethnic group now permits analysis of age-specific

205 nt increases in KS rates in any age, sex, or racial/ethnic group or in any geographic region or state

206 n, particularly mortality disparities across racial/ethnic groups and along the urban/rural continuum

207 These associations were consistent across racial/ethnic groups and the spectrum of glomerular filt

208 Outcomes for other racial/ethnic groups have been insufficiently studied.

209 Racial/ethnic groups have significant heterogeneity, yet

210 rcoma (KS) rates might be increasing in some racial/ethnic groups, age groups, and US regions.

211 presents at earlier ages than in most other racial/ethnic groups.

212 s for the overall population and three major racial/ethnic groups.

213 es for FFMI and FMI in children for specific racial/ethnic groups.

214 butable to objectively measured sleep across racial/ethnic groups.

215 us disease 2019 (COVID-19) differ among U.S. racial/ethnic groups.

216 e DNA methylation signatures of NAFLD across racial/ethnic groups.

217 ositive cancer and with broader inclusion of racial/ethnic groups.

218 ible recall biases, and the unrepresentative racial/ethnic makeup of the population.

219 s were younger (p < .001), more likely to be racial/ethnic minorities (p < .001), and more highly sen

220 Racial/ethnic minorities and SES disadvantage patients f

221 ption despite guidelines, particularly among racial/ethnic minorities and socioeconomically disadvant

222 es and changes in relative disparities among racial/ethnic minorities for singleton live births to wo

223 VP, there were 465 (41%) elderly, 380 (34%) racial/ethnic minorities, and 479 (43%) SES disadvantage

224 over time may help more patients, especially racial/ethnic minorities, get waitlisted and pursue dece

225 sing, air pollution, women, 20-49-year-olds, racial/ethnic minorities, residential segregation, incom

226 the association was generally stronger among racial/ethnic minorities.

227 lescents, low-income households, and several racial/ethnic minorities.

228 oV-2 infection may disproportionately affect racial/ethnic minorities; however, patient-level observa

229 nces, focusing on the sleep of the following racial/ethnic minority categories that are defined by th

230 tudies focused exclusively on experiences of racial/ethnic minority older adults.

231 Women and individuals of a specific racial/ethnic minority or minority religious affiliation

232 have focused on a population of inner-city, racial/ethnic minority youth during the transition from

233 are low-income, uninsured, and/or members of racial/ethnic minority, immigrant, or rural populations

234 not report race, identified with a specific racial/ethnic minority, or were politically conservative

235 Females with racial/ethnic non-response were least likely, while whit

236 Sexual harassment, racial/ethnic prejudice, or discrimination based on sexu

237 tricular ejection fraction across a range of racial/ethnic subgroups in a separate testing cohort (n=

238 t performed similarly well across a range of racial/ethnic subgroups in the testing cohort with an AU

239 cohort with an AUC of at least 0.930 in all racial/ethnic subgroups.

240 with those at the margins of societies (eg, racial/ethnic/sexual/gender minorities), who disproporti

241 a higher diabetes burden compared with other racial/ethnical populations in the country.

242 in age-specific COVID-19 mortality rates by racial/ethnicity and to calculate the impact of this mor

243 ents who were black, Hispanic, or of another racial/ethnicity minority spent significantly more days

244 cinations, previously reported to narrow the racial gap in vaccination among NH residents, should be

245 The high burden of SCD and the racial-gender disparities observed in our study represen

246 y, DRAMS re-assigned all data to the correct racial group in the 1000 Genomes project.

247 ow deportation or its consequences affects a racial group that the US immigration regime targets disp

248 carried the ADH1B*2 allele (86%) than other racial groups (4%-13%).

249 tment or recurrence, and 14 women from small racial groups (white and Asian women in South Africa), w

250 ed disparities of HBV infection among ethnic/racial groups and between U.S.-born and foreign-born per

251 Discrepancies amongst racial groups and income quartiles are present.

252 Health disparities across ethnic or racial groups are typically examined through single beha

253 we found extensive differences among ethnic-racial groups in the propensity to store fat intra-abdom

254 though associated with increased risk in all racial groups, high polygenic score demonstrated the str

255 After statistical balancing of the racial groups, the difference between black and white pa

256 ocumented cardiovascular disparities between racial groups, within-race determinants of cardiovascula

257 2.1 +/- 3.7, p = 0.05) compared to all other racial groups.

258 pattern of density loss was observed in both racial groups.

259 sease in which outcomes vary among different racial groups.

260 old varied in a similar pattern among ethnic-racial groups.

261 nds were generally consistent across sex and racial groups.

262 of mutation burden varies appreciably among racial groups.

263 incidence and mortality rates differ between racial groups.

264 present, this article frames a discussion of racial health disparities through a resilience approach

265 argeting mitochondria to reduce or eliminate racial health disparities.

266 thms have been shown to encode and reinforce racial health inequities, prioritizing the needs of whit

267 With each 0.1 increase in the racial ICE, the rate increased by 1.5% (95% CI: 1.5%, 1.

268 Of the 21 mix-ups involving errors of racial identity, DRAMS re-assigned all data to the corre

269 gher values indicate more deprivation) and a racial index of concentration at the extreme (ICE) (rang

270 justice and diversity in medicine stems from racial inequalities and discrimination that have permeat

271 fic regional structures of interpersonal and racial inequality that have "deep roots" generate persis

272 accustomed the United States is to profound racial inequality.

273 pandemic compare to another US catastrophe: racial inequality?

274 This inequity may, in part, drive racial inequities in HF outcomes.

275 In adjusted analyses, racial inequities in vaccination were more prominent at

276 s environments, especially as they relate to racial inequities, are poorly understood.

277 teps required to begin correcting historical racial injustices.

278 rates than novel contributions by gender and racial majorities, and equally impactful contributions o

279 Affected patients were more likely to be racial minorities (44.6% vs 36.5% of unaffected group, P

280 qually impactful contributions of gender and racial minorities are less likely to result in successfu

281 r example, novel contributions by gender and racial minorities are taken up by other scholars at lowe

282 Racial minorities in the United States have reported exp

283 9i rejection rates were observed with women, racial minorities, and lower-income groups.

284 from low socioeconomic backgrounds and some racial minorities.

285 g a marked jump within the highest decile of racial minority-serving extent (45.7% vs 36.7%; OR [95%

286 re likely to be men, and less likely to be a racial minority.

287 elf-identifying as Asian (n = 32), Bi-/multi-racial (n = 10), Black (n = 22), White (n = 23), Latino

288 ion researchers must consider how systems of racial oppression affect the environmental factors that

289 l population, but few studies have evaluated racial or ethnic disparities, and none have assessed pot

290 ng children and adolescents of all non-white racial or ethnic groups, people living in US-affiliated

291 zed (mean age, 67.6 years; 46% women; 31% of racial or ethnic minority), 934 (71%) completed the stud

292 census tracts with present-day economic and racial privilege, whereas the best historical HOLC grade

293 f neighborhood socioeconomic deprivation and racial segregation on organ donor registration rates.

294 Corporation (HOLC) nationalized residential racial segregation via "redlining," whereby HOLC designa

295 he significance of examining research from a racial/socioeconomic equity lens.

296 he significance of examining research from a racial/socioeconomic equity lens.

297 oth within a minority community and in wider racial, sociopolitical, and public health structures.

298 separate neural network was able to discern racial subgroup category (black/African American [AUC, 0

299 In this study, we observed racial variation in age-specific mortality rates not ful

300 etermined by the derivation population or by racial variation in the ECG.